Richter's Transformation after CD-19 Directed CAR-T Cells for Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)

被引：2
|
作者：
Blackmon, Amanda [1 ]
Danilov, Alexey V. [2 ]
Wang, Lili [3 ]
Pillai, Raju [4 ]
Mirshkarlo, Hormoz Babaei [5 ]
Rosen, Steven T. [6 ]
Siddiqi, Tanya [1 ]
机构：
[1] City Hope Natl Med Ctr, Dept Hematol & Hematopoiet Cell Transplantat, Duarte, CA USA
[2] City Hope Comprehens Canc Ctr, Duarte, CA USA
[3] City Hope Natl Med Ctr, Beckman Res Inst, Dept Syst Biol, Monrovia, CA USA
[4] City Hope Natl Med Ctr, Dept Pathol, Duarte, CA USA
[5] City Hope Natl Med Ctr, Duarte, CA USA
[6] City Hope Natl Med Ctr, Dept Hematol & Hematopoiet Cell Transplantat, Duarte, CA USA
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-149815
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1430
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Safety and Efficacy of CD19-CAR T Cells in Richter's Transformation after Targeted Therapy for Chronic Lymphocytic Leukemia
    Benjamini, Ohad
    Shimoni, Avichai
    Besser, Michal
    Shem-Tov, Noga
    Danylesko, Ivetta
    Yerushalmi, Ronit
    Merkel, Drorit Grizim
    Tadmor, Tamar
    Lavie, David
    Fineman, Riva
    Jacobi, Elad
    Nagler, Arnon
    Avigdor, Abraham
    BLOOD, 2020, 136
  • [2] HOME BREWN 3G.CD19.CAR T CELLS FOR RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) - (HD-CAR-1)
    Schmitt, M.
    Derigs, P.
    Dreger, P.
    Schmitt, A.
    Schubert, M. -L.
    Kunz, A.
    Mueller-Tidow, C.
    Brueggemann, M.
    Kobbe, G.
    HUMAN GENE THERAPY, 2022, 33 (7-8) : A15 - A16
  • [3] Successful Treatment of Refractory and Relapsed CNS Acute Lymphoblastic Leukemia With CD-19 CAR-T Immunotherapy: A Case Report
    Htun, Kyaw Thu
    Gong, Qiang
    Ma, Le
    Wang, Ping
    Tan, Ya
    Wu, Guangsheng
    Chen, Jieping
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [4] CD19 CAR-T Cells Are Highly Effective in Ibrutinib-Refractory Chronic Lymphocytic Leukemia
    Turtle, Cameron J.
    Hanafi, Laila-Aicha
    Li, Daniel
    Chaney, Colette
    Heimfeld, Shelly
    Riddell, Stanley R.
    Maloney, David G.
    BLOOD, 2016, 128 (22)
  • [5] Hypogammaglobulinemia and Infection Risk in Chronic Lymphocytic Leukemia (CLL) Patients Treated with CD19-Directed Chimeric Antigen Receptor T (CAR-T) Cells
    Uy, Natalie F.
    Pequignot, Edward
    Frey, Noelle V.
    Davis, Megan
    Hexner, Elizabeth O.
    Schuster, Stephen J.
    Gill, Saar
    Loren, Alison W.
    Grupp, Stephan A.
    Melenhorst, J. Joseph
    Lacey, Simon F.
    Fraietta, Joseph A.
    Gilmore, Joan
    Lledo, Lester
    Hwang, Wei-Ting
    Siegel, Don L.
    Levine, Bruce L.
    June, Carl H.
    Porter, David L.
    BLOOD, 2020, 136
  • [6] CD-19 CAR-T cells for polyrefractory rheumatoid arthritis
    Lidar, Merav
    Rimar, Doron
    David, Paula
    Jacoby, Elad
    Shapira-Frommer, Ronnie
    Itzhaki, Orit
    Slobodin, Gleb
    Stern, Myriam D.
    Eshed, Iris
    Sanalla, Tamer
    Marcus, Ronit
    Shimoni, Avichai
    Yerushalmi, Ronit
    Tov, Noga Shem
    Danylesko, Ivetta
    Avigdor, Abraham
    ANNALS OF THE RHEUMATIC DISEASES, 2025, 84 (02) : 370 - 372
  • [7] Varnimcabtagene Autoleucel (ARI-0001) for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) and Richter Transformation (RT)
    Ortiz-Maldonado, Valentin
    Martinez-Cibrian, Nuria
    Del Campo Balguerias, Gonzalo
    Espanol-Rego, Marta
    Navarro, Sergio
    Lopez-Oreja, Irene
    Nadeu, Ferran
    Cobo, Amparo
    Brillembourg, Helena
    Alserawan, Leticia
    Castella, Maria
    Benitez-Ribas, Daniel
    Magnano, Laura
    Gonzalo Correa, Juan
    Rivero, Andrea
    Mozas, Pablo
    Gine, Eva
    Gerardo Rodriguez-Lobato, Luis
    Martinez-Roca, Alexandra
    Montoro-Lorite, Mercedes
    Ayora, Pilar
    Fernandez de Larrea, Carlos
    Pascal, Mariona
    Setoain, Xavier
    Esteve Reyner, Jordi
    Urbano-Ispizua, Alvaro
    Juan, Manel
    Delgado, Julio
    BLOOD, 2023, 142
  • [8] Late Events After CD-19 CAR-T Treatment
    Hossain, Nasheed M.
    Nishimura, Michael I.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (01) : E1 - E2
  • [9] CAR-T Cells in Chronic Lymphocytic Leukemia
    Testa, Ugo
    Pelosi, Elvira
    Castelli, Germana
    Fresa, Alberto
    Laurenti, Luca
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2024, 16 (01)
  • [10] Relapsed or Refractory CLL after CD19-Specific CAR-T Therapy: Treatment Patterns and Clinical Outcomes
    Shadman, Mazyar
    Gauthier, Jordan
    Khajavian, Sirin
    Hirayama, Alexandre V.
    Lynch, Ryan C.
    Smith, Stephen D.
    Ujjani, Chaitra S.
    Chow, Victor A.
    Kiem, Hans-Peter
    Till, Brian G.
    Gopal, Ajay K.
    Maloney, David G.
    Turtle, Cameron J.
    BLOOD, 2019, 134
12345